annual SGA:
$94.52M+$14.13M(+17.57%)Summary
- As of today (September 17, 2025), AMPH annual SGA is $94.52 million, with the most recent change of +$14.13 million (+17.57%) on December 31, 2024.
- During the last 3 years, AMPH annual SGA has risen by +$25.60 million (+37.15%).
- AMPH annual SGA is now at all-time high.
Performance
AMPH SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$27.86M(-100.00%)Summary
- As of today (September 17, 2025), AMPH quarterly SGA is $0.00, with the most recent change of -$27.86 million (-100.00%) on June 30, 2025.
- Over the past year, AMPH quarterly SGA has dropped by -$22.30 million (-100.00%).
- AMPH quarterly SGA is now -100.00% below its all-time high of $27.86 million, reached on March 31, 2025.
Performance
AMPH quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$2.32B+$134.71M(+6.17%)Summary
- As of today (September 17, 2025), AMPH TTM SGA is $2.32 billion, with the most recent change of +$134.71 million (+6.17%) on June 30, 2025.
- Over the past year, AMPH TTM SGA has increased by +$2.23 billion (+2530.62%).
- AMPH TTM SGA is now at all-time high.
Performance
AMPH TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
AMPH Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.6% | -100.0% | +2530.6% |
| 3 y3 years | +37.1% | -100.0% | +3518.9% |
| 5 y5 years | +49.8% | -100.0% | +3627.2% |
AMPH Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +41.9% | -100.0% | at low | at high | +202.2% |
| 5 y | 5-year | at high | +49.8% | -100.0% | at low | at high | +389.0% |
| alltime | all time | at high | +209.6% | -100.0% | at low | at high | +3643.2% |
AMPH Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $51.68M(-30.1%) |
| Mar 2025 | - | $27.86M(>+9900.0%) | $73.97M(+4.0%) |
| Dec 2024 | $94.52M(+17.6%) | $0.00(-100.0%) | $71.16M(-23.4%) |
| Sep 2024 | - | $23.82M(+6.8%) | $92.90M(+5.4%) |
| Jun 2024 | - | $22.30M(-11.0%) | $88.15M(+3.9%) |
| Mar 2024 | - | $25.05M(+15.2%) | $84.85M(+5.5%) |
| Dec 2023 | $80.39M(+20.7%) | $21.74M(+14.1%) | $80.39M(+7.5%) |
| Sep 2023 | - | $19.06M(+0.3%) | $74.75M(+3.2%) |
| Jun 2023 | - | $19.00M(-7.7%) | $72.46M(+4.7%) |
| Mar 2023 | - | $20.59M(+27.9%) | $69.19M(+3.9%) |
| Dec 2022 | $66.59M(-3.4%) | $16.10M(-4.0%) | $66.59M(+2.2%) |
| Sep 2022 | - | $16.77M(+6.6%) | $65.19M(+1.7%) |
| Jun 2022 | - | $15.73M(-12.5%) | $64.08M(-4.4%) |
| Mar 2022 | - | $17.99M(+22.4%) | $67.03M(-2.7%) |
| Dec 2021 | $68.92M(+5.8%) | $14.70M(-6.1%) | $68.92M(-1.6%) |
| Sep 2021 | - | $15.65M(-16.3%) | $70.04M(+0.4%) |
| Jun 2021 | - | $18.69M(-5.9%) | $69.74M(-1.8%) |
| Mar 2021 | - | $19.88M(+25.6%) | $70.99M(+9.0%) |
| Dec 2020 | $65.16M(+3.2%) | $15.82M(+3.1%) | $65.16M(+2.9%) |
| Sep 2020 | - | $15.35M(-23.1%) | $63.32M(+1.8%) |
| Jun 2020 | - | $19.95M(+42.1%) | $62.21M(+7.9%) |
| Mar 2020 | - | $14.04M(+0.4%) | $57.68M(-8.6%) |
| Dec 2019 | $63.11M(+8.7%) | $13.98M(-1.8%) | $63.11M(-3.7%) |
| Sep 2019 | - | $14.24M(-7.6%) | $65.54M(-1.7%) |
| Jun 2019 | - | $15.42M(-20.8%) | $66.67M(+2.9%) |
| Mar 2019 | - | $19.47M(+18.6%) | $64.79M(+11.6%) |
| Dec 2018 | $58.04M | $16.41M(+6.8%) | $58.04M(+10.6%) |
| Sep 2018 | - | $15.37M(+13.5%) | $52.48M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $13.54M(+6.5%) | $50.53M(-0.6%) |
| Mar 2018 | - | $12.72M(+17.2%) | $50.82M(-0.2%) |
| Dec 2017 | $50.92M(+7.7%) | $10.85M(-19.2%) | $50.92M(-2.6%) |
| Sep 2017 | - | $13.42M(-3.0%) | $52.26M(+2.6%) |
| Jun 2017 | - | $13.83M(+7.9%) | $50.93M(+6.3%) |
| Mar 2017 | - | $12.82M(+5.1%) | $47.89M(+1.3%) |
| Dec 2016 | $47.30M(+0.7%) | $12.19M(+0.8%) | $47.30M(+4.8%) |
| Sep 2016 | - | $12.09M(+12.1%) | $45.12M(+4.4%) |
| Jun 2016 | - | $10.79M(-11.7%) | $43.23M(-4.4%) |
| Mar 2016 | - | $12.22M(+22.0%) | $45.22M(-3.7%) |
| Dec 2015 | $46.97M(+16.4%) | $10.02M(-1.8%) | $46.97M(-2.6%) |
| Sep 2015 | - | $10.21M(-20.1%) | $48.22M(-1.6%) |
| Jun 2015 | - | $12.78M(-8.6%) | $49.03M(+6.0%) |
| Mar 2015 | - | $13.97M(+24.0%) | $46.24M(+16.4%) |
| Dec 2014 | $40.37M(+11.2%) | $11.27M(+2.3%) | $39.73M(+5.2%) |
| Sep 2014 | - | $11.01M(+10.2%) | $37.76M(+0.0%) |
| Jun 2014 | - | $9.99M(+33.8%) | $37.76M(+6.4%) |
| Mar 2014 | - | $7.47M(-19.7%) | $35.49M(-2.3%) |
| Dec 2013 | $36.32M(+14.8%) | $9.30M(-15.6%) | $36.32M(+4.2%) |
| Sep 2013 | - | $11.01M(+42.7%) | $34.85M(+10.4%) |
| Jun 2013 | - | $7.72M(-7.0%) | $31.57M(-0.1%) |
| Mar 2013 | - | $8.30M(+6.0%) | $31.59M(-0.2%) |
| Dec 2012 | $31.65M(+3.7%) | - | - |
| Dec 2012 | - | $7.83M(+1.3%) | $31.65M(+32.9%) |
| Sep 2012 | - | $7.73M(-0.1%) | $23.82M(+48.0%) |
| Jun 2012 | - | $7.73M(-7.5%) | $16.09M(+92.5%) |
| Mar 2012 | - | $8.36M | $8.36M |
| Dec 2011 | $30.53M | - | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual SGA?
- What is the all time high annual SGA for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual SGA year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly SGA year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. TTM SGA?
- What is the all time high TTM SGA for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. TTM SGA year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual SGA?
The current annual SGA of AMPH is $94.52M
What is the all time high annual SGA for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual SGA is $94.52M
What is Amphastar Pharmaceuticals, Inc. annual SGA year-on-year change?
Over the past year, AMPH annual SGA has changed by +$14.13M (+17.57%)
What is Amphastar Pharmaceuticals, Inc. quarterly SGA?
The current quarterly SGA of AMPH is $0.00
What is the all time high quarterly SGA for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly SGA is $27.86M
What is Amphastar Pharmaceuticals, Inc. quarterly SGA year-on-year change?
Over the past year, AMPH quarterly SGA has changed by -$22.30M (-100.00%)
What is Amphastar Pharmaceuticals, Inc. TTM SGA?
The current TTM SGA of AMPH is $2.32B
What is the all time high TTM SGA for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high TTM SGA is $2.32B
What is Amphastar Pharmaceuticals, Inc. TTM SGA year-on-year change?
Over the past year, AMPH TTM SGA has changed by +$2.23B (+2530.62%)